United States Patent and Trademark Office
Home
|
Site Index
|
Search
|
Guides
|
Contacts
|
e
Business
|
eBiz alerts
|
News
|
Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0
Summary
Query:
Party Name contains all words: INTRA-CELLULAR THERAPIES, INC.
Number of results:
9
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
91238565
12/14/2017
Intra-Cellular Therapies, Inc.
Mark:
KIPLYTA
S#:
87334207
Mark:
KYPLEETA
S#:
87334209
Novartis AG
Mark:
KYNVYTA
S#:
79186275
R#:
5033986
91237307
10/18/2017
Intra-Cellular Therapies, Inc.
Mark:
CAMLYRA
S#:
87334143
Boehringer Ingelheim International GmbH
Mark:
SAMLYRA
S#:
79190967
R#:
5111796
91237305
10/18/2017
Intra-Cellular Therapies, Inc.
Mark:
CAMLYR
S#:
87334225
Boehringer Ingelheim International GmbH
Mark:
SAMLYRA
S#:
79190967
R#:
5111796
91237303
10/18/2017
Intra-Cellular Therapies, Inc.
Mark:
CAPLYRA
S#:
87334173
Boehringer Ingelheim International GmbH
Mark:
SAMLYRA
S#:
79190967
R#:
5111796
87334143
07/20/2017
INTRA-CELLULAR THERAPIES, INC.
Mark:
CAMLYRA
S#:
87334143
Boehringer Ingelheim International GmbH
87334225
07/20/2017
INTRA-CELLULAR THERAPIES, INC.
Mark:
CAMLYR
S#:
87334225
Boehringer Ingelheim International GmbH
87334173
07/20/2017
INTRA-CELLULAR THERAPIES, INC.
Mark:
CAPLYRA
S#:
87334173
Boehringer Ingelheim International GmbH
87334209
07/14/2017
INTRA-CELLULAR THERAPIES, INC.
Mark:
KYPLEETA
S#:
87334209
Novartis AG
87334207
07/14/2017
INTRA-CELLULAR THERAPIES, INC.
Mark:
KIPLYTA
S#:
87334207
Novartis AG
Novartis AG
Results as of 09/12/2024 12:57 AM
Search again
|
.
HOME
|
INDEX
|
SEARCH
|
e
BUSINESS
|
CONTACT US
|
PRIVACY POLICY